CIMB Tempo Scan Pacific Quick takes - Ceasing coverage

(TSPC IJ / TSPC.JK, Ceased coverage, Rp640, Healthcare)

We are ceasing coverage of Tempo Scan. Post-tender offer, the public now owns less than 5% of its outstanding shares, while daily stock trading has been less than Rp1bn. We had an Outperform rating previously with a target price of Rp869, based on DCF valuation.